Liminatus Pharma LIMN
NASDAQ LIMN
$3.88 +0.13 (+3.47%)
As of: Oct 2, 2026 · 11:47 AM EDT

Liminatus Pharma (LIMN) Depreciation & Amortization (CF) (2025 - 2026)

Updated

Liminatus Pharma (LIMN) recorded Depreciation & Amortization (CF) of $468.00 in Q2 2026, down 9.7% from the prior quarter.

Analysis

Liminatus Pharma (LIMN) Depreciation & Amortization (CF) (2025 - 2026) Analysis & Trends

On a TTM basis, Liminatus Pharma's Depreciation & Amortization (CF) came in at $2,071 as of Jun 30, 2026; for FY2025, it was $1,828.

  • Per Business Quant, the preceding three quarters came in at $518.00 (Q1 2026), $543.00 (Q4 2025) and $542.00 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Liminatus Pharma 4.18 Mn 4.18 Mn - 468.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 468.00
Mar 31, 2026 518.00
Dec 31, 2025 543.00
Sep 30, 2025 542.00
API Access

Liminatus Pharma Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=LIMN&period=max&api_key=YOUR_API_KEY